Clinical Trials in India: Brazen Cocktail of Corporate Crimes, Corrupt Government and Exploitation of the Poor
Newsclick Production, May 07, 2013
The Parliamentary Committee report on health tabled in the Parliament last month shockingly exposes the reckless attitude and the complicity of the Health Ministry, Drug Controller General of India's office and the Central Drug Standard Control Organisation in helping Multinational pharmaceutical companies in conducting clinical trials on poor patients in India leading to 2644 deaths during clinical trials since 2005. Neha Dixit interviews Amulya Nidhi, co-convenor of Swasthya Adhikar Manch, the organisation that filed the much needed petition on Clinical trials in the Supreme Court of India which opened a pandora's box on the issue and helped hold the Union of India accountable.
Akhlas Ahmad, AJK MCRC , Jamia Milia Islamia University, March 16, 2013
Thousands of migrant labourers travel to metropolitan cities all around the year searching for work due to pathetic conditions back home. Akhlas Ahmad met some of them in Delhi.
Newsclick Production, February 27, 2013
Kalyani Menon Sen, activist and feminist researcher discusses with Newsclick the importance of access to drugs, specially in certain life-threatening diseases. Today, a lot of women are getting affected with breast cancer. According to the national cancer registry, over 1,00,000 women in India develop breast cancer every year. Herceptin is a drug which is useful in the most aggressive form of the cancer, which typically afflicts younger patients. But its cost is prohibitive for almost any Indian patient to afford. Given the drug’s important public health benefit, Kalyani Menon Sen feels that Indian government should issue compulsory license and make the drug accessible to a large number of women.
Amit Sengupta, Newsclick, November 7, 2012
In 2007 the Government of Andhra Pradesh launched an insurance scheme that was designed to protect patients from the ‘catastrophic’ impact of out of pocket expenses incurred on hospital care.
Newsclick Production, October 1, 2012
Dr. Satyajit Rath discusses with Newsclick exciting new results that go in to understanding the differences between immune responses of placental mammals and others. This partly unravels the mystery of why the mother's immune system does not reject the embryo which has genetic material that is partly foreign to the mother's.
Dr. Amit Sengupta, Newsclick, August 17, 2012
A few months back the Planning Commission of India had put its foot squarely in its mouth by claiming that the poverty line in India can be pegged at a consumption expenditure of Rs.28.65 per day.
Newsclick Production, August 17, 2012
Newsclick Production, 25-March-2012
Prof. Sarah Hodges, University of Warwick, explains her research on "family planning" and reproductive health in colonial India.
Newsclick Production, 15-Jun-2011
Many unsuspecting people in India, subject to clinical trials, have suffered fatalities. Newsclick examines this issue in the light of a government committee report on the HPV vaccine controversy. This Newsclick feature also follows up an earlier production on the HPV vaccine issue.
Newsclick Production, May 2, 2011
Scientist at the National Institute of Immunology, Dr. Satyajith Rath and Dr Amit Sengupta of the All India Peoples' Science Network discuss the recent Lancet report on the "Delhi Superbug". A Newsclick presentation.